About Forkhead box protein D4
Forkhead box protein D4 (FOXD4) is a protein
from Homo sapiens identified by UniProt accession
Q12950, 439 residues long.
MolForge cross-references it against 0 known binders and
50 disease associations.
Target properties
| Protein name | Forkhead box protein D4 |
| UniProt accession | Q12950 |
| Gene | FOXD4 |
| Organism | Homo sapiens |
| Length | 439 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (50)
Diseases linked to this target (Open Targets).
- mean platelet volume · score 0.12
- platelet component distribution width · score 0.09
- platelet count · score 0.08
- Isolated anophthalmia - microphthalmia · score 0.05
- Microphthalmia - ankyloblepharon - intellectual disability · score 0.05
- monocyte percentage of leukocytes · score 0.04
- nanophthalmia · score 0.04
- microphthalmia · score 0.04
- nanophthalmos 2 · score 0.04
- Red cell distribution width · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q12950-F1 | alphafold | PREDICTED | 55.68 | — |
Amino-acid sequence (439 residues)
MNLPRAERLR STPQRSLRDS DGEDGKIDVL GEEEDEDEEE AASQQFLEQS LQPGLQVARW GGVALPREHI EGGGGPSDPS EFGTEFRAPP RSAAASEDAR QPAKPPSSYI ALITMAILQS PHKRLTLSGI CAFISDRFPY YRRKFPAWQN SIRHNLSLND CFVKIPREPG RPGKGNYWSL DPASQDMFDN GSFLRRRKRF QRHQPTPGAH LPHPFPLPAA HAALHNPRPG PLLGAPAPPQ PVPGAYPNTG PGRRPYALLH PHPPRYLLLS APAYAGAPKK AEGADLATPA PFPCCSPHLV LSLGRRARVW RRHREADASL SALRVSCKGS GERVQGLRRV CPRPRGATAP CSSDRQACRT ILQQQQRHQE EDCANGCAPT KGAVLGGHLS AASALLRYQA VAEGSGLTSL AAPLGGEGTS PVFLVSPTPS SLAESAGPS
Explore Forkhead box protein D4 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets